Global Next Generation Sequencing Services Market Size Study, By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), By Service Type (Targeted Resequencing and Custom Gene Panels, RNA-Seq, De Novo Sequencing, Exome Sequencing, Chip-Seq, Whole-Genome Sequencing, Methyl-Seq), By Application, By End User and Regional Forecast, 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Next Generation Sequencing market is valued at approximately USD 3.5 billion in 2016. The market growth is attributed to various factors such as growing applications of next-generation sequencing, rising technological innovations in sequencing platforms. Further increasing demand for drug discovery and increasing research spending are some other prominent drivers of the market. However, data storage and analysis are still a major concern before handling the complex sequencing data.

Global Next Generation Sequencing MarketApplications:

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture and Animal Research
  • Other Applications

Technology:

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Sequencing By Ligation (SBL)
  • Pyrosequencing
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Other Technologies

End User:

  • Research Centres And Academic & Government Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Regions:

  • North America
    • The U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Among various NGS technologies discussed in the report, currently, the SBS technology is expected to account for the largest revenue share of the market. Development of advanced NGS platforms and the increasing demand for Illumina’s systems are the primary growth attributes for the growth of SBS technology. On the basis of applications, the market is dominated by diagnostic applications with the highest revenue share in 2016. Companies are constantly focusing on the development of NGS based diagnostic tests. Recently, in July 2017, FDA has approved the first NGS-based diagnostic test to Thermo Fisher Scientific.

Regionally, the market is dominated by North America region. The growth in the region is driven by the rising number of collaboration among research institution in the region. Moreover, increasing focus of research institutes towards drug discovery is another key driving factor. However, Asia Pacific region is anticipated to grow with the eye-popping CAGR of during the forecasted period in the global market. The growth in the region is majorly driven by increasing and developing healthcare infrastructure in the region.

Some of the key market players are Life Sciences Corporation (Roche Holding), Agilent Technologies, Inc., Beijing Genomics Institute, GE Healthcare, Illumina Inc., Newgene Ltd., Novartis, OXFORD GENE TECHNOLOGY, OXFORD NANOPORE TECHNOLOGIES, Pacific Biosciences of California Inc., Siemens, Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.

Chapter 1.           Research Methodology

1.1.         Research Process

1.1.1.     Data Mining

1.1.2.     Analysis

1.1.3.     Market Estimation

1.1.4.     Validation

1.1.5.     Publishing

1.2.         Research Assumption

Chapter 2.           Global Next Generation Sequencing Market Definition & Scope

2.1.         Objective of The Study

2.2.         Market Definition

2.3.         Scope of The Study

2.4.         Years Considered for The Study

2.5.         Currency Conversion Rates

2.6.         Report Limitation

Chapter 3.           Executive Summary

3.1.         Key Trends

3.2.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)

Chapter 4.           Global Next Generation Sequencing Industry Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.3.         Porter’s 5 Force Model

4.4.         PEST Analysis

4.5.         Value Chain Analysis

4.6.         Analyst Recommendation & Conclusion

Chapter 5.           Global Next Generation Sequencing Market by Application

5.1.         Market Snapshot

5.2.         Next Generation Sequencing Market, Sub Segment Analysis

5.2.1.     Diagnostics

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.2.     Drug Discovery

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.3.     Biomarker Discovery

5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.4.     Personalized Medicine

5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.5.     Agriculture and Animal Research

5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.6.     Other Applications         

5.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 6.           Global Next Generation Sequencing Market by Technology

6.1.         Market Snapshot

6.2.         Next Generation Sequencing Market, Sub Segment Analysis

6.2.1.     Sequencing by Synthesis (SBS)

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.2.     Ion Semiconductor Sequencing

6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.3.     Sequencing by Ligation (SBL)

6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.4.     Pyrosequencing

6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.5.     Single-Molecule Real-Time Sequencing (SMRT)

6.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.6.     Other Technologies

6.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 7.           Global Next Generation Sequencing Market by End User

7.1.         Market Snapshot

7.2.         Next Generation Sequencing Market, Sub Segment Analysis

7.2.1.     Research Centres and Academic & Government Institutes

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.2.2.     Hospitals & Clinics

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.2.3.     Pharmaceutical & Biotechnology Companies 2014-2022

7.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.2.4.     Other End Users

7.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 8.           Global Next Generation Sequencing Market, Regional Analysis

8.1.         Next Generation Sequencing   Market, Regional Market Snapshot (2015-2025)

8.2.         North America Next Generation Sequencing Market Snapshot

8.2.1.     U.S. Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.1.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.2.1.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.2.1.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.2.2.     Canada Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.2.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.2.2.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.2.2.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.         Europe Next Generation Sequencing Market Snapshot

8.3.1.     U.K. Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.3.1.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.1.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.1.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.2.     Germany Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.3.2.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.2.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.2.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.3.     France Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.3.3.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.3.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.3.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.4.     Rest of Europe Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.3.4.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.4.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.3.4.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.         Asia Next Generation Sequencing Market Snapshot

8.4.1.     China Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.4.1.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.1.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.1.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.2.     India Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.4.2.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.2.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.2.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.3.     Japan Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.4.3.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.3.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.3.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.4.     Rest of Asia Pacific Next Generation Sequencing Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.4.4.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.4.3. Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.4.4.4. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.5.         Rest of The World Next Generation Sequencing Market Snapshot

8.5.1.     Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.5.2.     Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.5.3.     Technology breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

8.5.4.     End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 9.           Competitive Intelligence

9.1.         Company Market Share (Subject to Data Availability)

9.2.         Top Market Strategies

9.3.         Company Profiles

9.3.1.     Agilent Technologies

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2.     Eurofins Scientific

9.3.3.     F. Hoffmann-La Roche AG

9.3.4.     GATC Biotech Ag

9.3.5.     Illumina Incorporated

9.3.6.     Macrogen, Inc.

9.3.7.     Oxford Nanopore Technologies Ltd.

9.3.8.     Pacific Biosciences of California, Inc.

9.3.9.     Perkin Elmer, Inc.

9.3.10.   Qiagen NV

9.3.11.   Thermo Fischer Scientific Inc.

 

 

 

The research for global Next Generation Sequencing(NGS) market focuses deeply on the entire value chain of the market. However, the market numbers are calculated purely based on the end user side of the value chain wherein the market sizes have been calculated by assuming the investments and development across various end-user segments such as research & development institutes, biotechnology companies, pharmaceutical companies, academic institutions. Some key data points considered to calculate the revenue for global NGS market include:

  • Increasing geriatric population
  • R&D investments in drug discovery technology
  • Regulatory compliance for adoption of NGS technology
  • Revenue generated by companies in different geographies

Each of our research reports, go through an extensive process of primary and secondary research. Various government websites/portals and paid data sources are considered as the key source of secondary research. Our team of analysts conducts extensive primary research across key industry people, through questionnaires, telephonic conversations, email conversations, and interviews.

 


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…